Important clinical and research data in the field of breast cancer presented during this prestigious meeting are reviewed in this material. The breast cancer sessions were marked by advances in prognostic and predictive markers, pharmacology, and, most notably, the treatment of metastatic breast cancer...
Denvax, A leading immunotherapy cancer treatment hospital in India. Enquire about the cost of immunotherapy services in India and other details. Schedule an Appointment Now!
In metastatic disease (MBC) it should be based on risk factors, predictive factors, toxicity, preference of the patient herself and available resources, and weighted against effect on quality of life and treatment costs. 展开 关键词: Humans Breast Neoplasms Antineoplastic Agents Cost of Illness ...
Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC).5007 Citation Information: Cancer Res 2009;69(2 Suppl)nr 5007... HL Mcarthur,C Lynch,P Morris,... - 《Cancer Research》 被引量:...
[4] André F, Hee Park Y, Kim SB, et al. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial. Lancet. 2023. 401(10390): 1773-1785. ...
Patients with HER2-positive metastatic breast cancer experienced a significant survival benefit when treated with fam-trastuzumab deruxtecan compared with trastuzumab emtansine.
The coronavirus disease 2019 pandemic had a tremendous impact on the surgical care of patients with breast cancer; practice patterns needed to be rapidly adjusted to continue to safely provide care during a time when resources were very limited.
Now that liver resection has become an accepted treatment for selected patients with colon cancer metastatic to the liver, this study was conducted to clarify the selection process. One hundred twenty-three patients who underwent liver resection for colorectal metastases were categorized into those with...
Metastasis is the leading cause of death in breast cancer patients. For metastasis to occur, tumor cells must invade locally, intravasate, and colonize distant tissues and organs, all steps that require tumor cell migration. The majority of studies on in
Well, let me just start out by saying that systemic therapy is the main treatment for metastatic breast cancer but local management of the primary tumor in the breast or a metastatic site may palliate symptoms, improve progression-free survival, and prevent complications....